Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-20 5:07 pm Purchase | 13D | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 8,696,205 23.9% | 2,203,688 (+33.94%) | View |
| 2023-11-07 4:41 pm Purchase | 13G | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 6,492,517 17.9% | 1,982,445 (+43.96%) | View |
| 2023-02-14 12:10 pm Sale | 13G | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 4,510,072 12.6% | -16,210 (-0.36%) | View |
| 2022-01-12 5:05 pm Purchase | 13G | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 4,526,282 14.1% | 1,425,000 (+45.95%) | View |
| 2022-01-12 5:03 pm Purchase | 13G | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 3,101,282 9.7% | 602,381 (+24.11%) | View |
| 2021-09-15 5:17 pm Purchase | 13G | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 2,498,901 7.7% | 2,498,901 (New Position) | View |